The story
Slovenia opened a prescription route for registered cannabinoid medicines through a drug-classification change approved on 19 June 2014.[1] The decree was published the following day and took effect fifteen days later, on 5 July.[2]
Patients had pressed for access
The Human Rights Ombudsman’s report for 2013 describes a person with a chronic illness who said cannabis helped and wanted to use it without fearing the police.[3] The Ombudsman asked the Health Ministry to explain what it was doing, while recognising that medical effectiveness needed professional assessment.[3]
The ministry reported that the Drugs Commission had discussed cannabis in June 2013 and sought opinions from six medical boards.[3] By its December response, only the psychiatry board had replied, opposing medical use and pointing to psychiatric risks.[3] The report therefore records a debate still taking place during 2013.[3]
A citizen bill preceded the decree
Civil society submitted a cannabis bill in December 2013 seeking medical permission.[1] Parliament rejected the bill, and the government used the classification decree to open access to registered cannabinoid medicines instead.[1]
NIJZ explained that doctors could prescribe these medicines for conditions where effectiveness was demonstrated, while cannabis itself remained controlled.[1] Its guidance directed patients toward medical advice and warned against abandoning prescribed treatment because of claims that cannabis could treat every disease.[1]
The change used medicine regulation
The decree divided controlled substances into three groups according to health risks and use, with the schedules forming part of the instrument.[2] It replaced the earlier classification decree and its amendments, including the 2013 amendment.[2] The prescription change thus operated through the existing medicine and controlled-drug framework.[1][2]
For patients, the immediate distinction was between a registered cannabinoid medicine prescribed by a doctor and cannabis obtained outside that route.[1] The decision did not authorise growing a personal medical crop.[1]
Pharmacy preparations followed
NIJZ’s later report on medicine consumption describes registered medicines, specially imported medicines and compounded preparations as access routes.[4] Its incomplete pharmacy returns for 2024 recorded 1,666 prescriptions and 2,091 compounded cannabinoid preparations.[4] The same report described flower and standardised extracts as permitted but not yet routinely used.[4]
The 2025 medical and scientific cannabis law later provided a separate domestic production framework, followed in the Slovenia profile.[5]
Score by segment 0 to 10
- Possession · 25%3 → 3
- Personal cultivation · 25%1 → 1
- Punishment & enforcement · 20%4 → 4
- Sharing & gifting · 10%1 → 1
- Consumption · 10%2 → 2
- Legal access · 10%0 → 1+1
The bar shows the score after the change; the tick marks where it stood before. Slovenia's scores have changed again since.
References
- NIJZ and Health Ministry — Cannabis in medicinePublished 19 June 2014; citizen bill and government decisionarchived
- Slovenia Official Gazette — Drug-classification decree, 2014Gazette 45/2014, published 20 June; article 5, effective 5 Julyarchived
- Slovenian Human Rights Ombudsman — Annual report for 2013PDF pp. 120–121, Using cannabis for medical purposesarchived
- NIJZ — Prescription medicine consumption in Slovenia in 2024Printed p. 163; cannabinoid preparations and pharmacy returnsarchived
- Official Gazette — Medical and Scientific Cannabis Act, 2025archived
Checked. The date and the event were compared with a source that was read. The score before the change is an editorial estimate.